Eyevensys Is A Clinical Stage Biotechnology Company Based In Parisfrancefocused On Developing Non Viral Gene Therapies For Ophthalmic Diseasesthe Company Utilizes Its Proprietary Eyeceteye Ciliary Muscle Electro Transfectiontechnology To Create Treatments That Enable The Eye To Produce Therapeutic Proteins Sustainablythis Innovative Approach Allows For Long Lasting Effectstypically Over Six Months The Company S Lead Producteys606Targets Non Infectious Uveitisa Major Cause Of Blindnessand Has Received Orphan Designation From The European Medicines Agencyeyevensys Is Also Developing Eys809 For Wet Age Related Macular Degeneration And Eys611 For Geographic Atrophy And Retinitis Pigmentosathe Company Has Secured Significant Funding To Support Its Research And Development Effortsincluding A $12 Million Series B Plus Funding Round In 2021
No conferences found for this company.
| Company Name | Eyevensys Sas |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
